![The Psoriasis Area and Severity Index Is the Adequate Criterion to Define Severity in Chronic Plaque-Type Psoriasis | Semantic Scholar The Psoriasis Area and Severity Index Is the Adequate Criterion to Define Severity in Chronic Plaque-Type Psoriasis | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/206b3763bd2ce81db7cd8b22499cd629438e6d66/4-Table2-1.png)
The Psoriasis Area and Severity Index Is the Adequate Criterion to Define Severity in Chronic Plaque-Type Psoriasis | Semantic Scholar
![Assessing the Impact of Improvements in PASI and Itch Scores on Patients' Quality of Life in the Treatment of Psoriasis | HTML | Acta Dermato-Venereologica Assessing the Impact of Improvements in PASI and Itch Scores on Patients' Quality of Life in the Treatment of Psoriasis | HTML | Acta Dermato-Venereologica](https://www.medicaljournals.se/acta/html-editor/html-img/5520/5520_19821.png)
Assessing the Impact of Improvements in PASI and Itch Scores on Patients' Quality of Life in the Treatment of Psoriasis | HTML | Acta Dermato-Venereologica
![Another PASI Calculator Mobile Medical App from Janssen: Simple, Sophisticated, But Short of a Full Deck - Pharma Marketing Network Another PASI Calculator Mobile Medical App from Janssen: Simple, Sophisticated, But Short of a Full Deck - Pharma Marketing Network](http://3.bp.blogspot.com/-mJYB19N2F0g/UopwPn5ZF-I/AAAAAAAAGc4/xRJNATI2yW4/s1600/PASI-JanssenKoreaScreen.jpg)
Another PASI Calculator Mobile Medical App from Janssen: Simple, Sophisticated, But Short of a Full Deck - Pharma Marketing Network
![Psoriasis Area and Severity Index (PASI) score assessment (H, head; LL,... | Download Scientific Diagram Psoriasis Area and Severity Index (PASI) score assessment (H, head; LL,... | Download Scientific Diagram](https://www.researchgate.net/publication/221929000/figure/fig2/AS:304724734693382@1449663446939/Psoriasis-Area-and-Severity-Index-PASI-score-assessment-H-head-LL-lower-limbs-T.png)
Psoriasis Area and Severity Index (PASI) score assessment (H, head; LL,... | Download Scientific Diagram
![Analysis of Body Regions and Components of PASI Scores During Adalimumab or Methotrexate Treatment for Patients With Moderate-to-Severe Psoriasis - JDDonline - Journal of Drugs in Dermatology Analysis of Body Regions and Components of PASI Scores During Adalimumab or Methotrexate Treatment for Patients With Moderate-to-Severe Psoriasis - JDDonline - Journal of Drugs in Dermatology](http://dl.jddonline.com/articleimages/article_2456/table1.png)
Analysis of Body Regions and Components of PASI Scores During Adalimumab or Methotrexate Treatment for Patients With Moderate-to-Severe Psoriasis - JDDonline - Journal of Drugs in Dermatology
![PASI vs PO‐PASI: Patient‐Oriented PASI (PO‐PASI) is comparable to clinician score PASI - Montes de Oca Pedrosa - 2022 - Australasian Journal of Dermatology - Wiley Online Library PASI vs PO‐PASI: Patient‐Oriented PASI (PO‐PASI) is comparable to clinician score PASI - Montes de Oca Pedrosa - 2022 - Australasian Journal of Dermatology - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/5e273e28-94f9-4a61-be41-3d02ba8af628/ajd13738-tbl-0001-m.jpg)
PASI vs PO‐PASI: Patient‐Oriented PASI (PO‐PASI) is comparable to clinician score PASI - Montes de Oca Pedrosa - 2022 - Australasian Journal of Dermatology - Wiley Online Library
![Life | Free Full-Text | Psoriasis Management Challenges Regarding Difficult-to-Treat Areas: Therapeutic Decision and Effectiveness Life | Free Full-Text | Psoriasis Management Challenges Regarding Difficult-to-Treat Areas: Therapeutic Decision and Effectiveness](https://pub.mdpi-res.com/life/life-12-02050/article_deploy/html/images/life-12-02050-g001.png?1670482868)
Life | Free Full-Text | Psoriasis Management Challenges Regarding Difficult-to-Treat Areas: Therapeutic Decision and Effectiveness
![Comparison of efficacy, safety, and cost-effectiveness of topical salicylic acid 6% versus clobetasol propionate 0.05% in the treatment of limited chronic plaque psoriasis Comparison of efficacy, safety, and cost-effectiveness of topical salicylic acid 6% versus clobetasol propionate 0.05% in the treatment of limited chronic plaque psoriasis](https://www.jhrr.org/articles/2018/5/2/images/JHealthResRev_2018_5_2_86_238863_f1.jpg)
Comparison of efficacy, safety, and cost-effectiveness of topical salicylic acid 6% versus clobetasol propionate 0.05% in the treatment of limited chronic plaque psoriasis
![Predicting Psoriasis Area Severity Index (PASI) using decision tree classifier - Mohammadreza's Homepage Predicting Psoriasis Area Severity Index (PASI) using decision tree classifier - Mohammadreza's Homepage](https://mohammadrezaazimi.github.io/images/PASI/table.png)